Click on the following links to read the articles:

Goldman Sachs Cuts Target Prices for China Healthcare Stocks (1-9-2012)

Morgan Stanley Slashes Guangzhou Pharmaceutical’s Target to HK$11 from HK$14.60 (4-14-2011)

Goldman Sachs Bullish on China Healthcare Sector; Revised Sector Players’ Targets (11-25-2010)